These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery. Murphy GS; Marymont JH J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):113-26. PubMed ID: 17289495 [No Abstract] [Full Text] [Related]
6. Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management. Shantsila E; Lip GYH; Chong BH Chest; 2009 Jun; 135(6):1651-1664. PubMed ID: 19497901 [TBL] [Abstract][Full Text] [Related]
7. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Garcia DA; Baglin TP; Weitz JI; Samama MM Chest; 2012 Feb; 141(2 Suppl):e24S-e43S. PubMed ID: 22315264 [TBL] [Abstract][Full Text] [Related]
8. Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures. Kodityal S; Manhas AH; Udden M; Rice L Eur J Haematol; 2003 Aug; 71(2):109-13. PubMed ID: 12890149 [TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopenia: what clinicians need to know. Chong BH; Isaacs A Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810 [No Abstract] [Full Text] [Related]
10. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia. Jeske WP; Walenga JM Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410 [TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia and thrombosis syndrome: in vivo cross-reactivity with danaparoid and successful treatment with r-Hirudin. Keng TB; Chong BH Br J Haematol; 2001 Aug; 114(2):394-6. PubMed ID: 11529862 [TBL] [Abstract][Full Text] [Related]
12. Heparin-induced thrombocytopenia in intensive care patients. Selleng K; Warkentin TE; Greinacher A Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253 [TBL] [Abstract][Full Text] [Related]
13. Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management. Napolitano LM; Warkentin TE; Almahameed A; Nasraway SA Crit Care Med; 2006 Dec; 34(12):2898-911. PubMed ID: 17075368 [TBL] [Abstract][Full Text] [Related]
15. Current agents for the treatment of patients with heparin-induced thrombocytopenia. Warkentin TE Curr Opin Pulm Med; 2002 Sep; 8(5):405-12. PubMed ID: 12172444 [TBL] [Abstract][Full Text] [Related]
17. Heparin-induced thrombocytopenia: a ten-year retrospective. Warkentin TE Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268 [TBL] [Abstract][Full Text] [Related]
18. Thrombosis during the use of the heparinoid Organon 10172 in a patient with heparin-induced thrombocytopenia. Insler SR; Kraenzler EJ; Bartholomew JR; Kottke-Marchant K; Lytle B; Starr NJ Anesthesiology; 1997 Feb; 86(2):495-8. PubMed ID: 9054269 [No Abstract] [Full Text] [Related]
19. Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium. Ranze O; Ranze P; Magnani HN; Greinacher A Eur J Pediatr; 1999 Dec; 158 Suppl 3():S130-3. PubMed ID: 10650852 [TBL] [Abstract][Full Text] [Related]
20. Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes. Rice L; Nguyen PH; Vann AR Postgrad Med; 2002 Sep; 112(3):85-9. PubMed ID: 12360660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]